type your search, and then press enter

News & Events

See what’s new in the field of hereditary eye diseases

Blog managed by the DBGen team, with updated therapies, news and events involving hereditary eye diseases. We invite you to take part in this forum.

RPGeNet v2.0 allows visualizing interactions of more than 270 causative genes of inherited retinal dystrophies

RPGeNet is a network dedicated to provide a graphical platform that links retinal dystrophies causative genes with their molecular interactors. The aim of this network is granting researchers a tool that allows them to understand the pathological process in its cellular and histological context, highlight key molecular players of retinal degeneration and unveil new candidate genes of these diseases (Boloc...

read more

Professor Gemma Marfany has been awarded the distinction of the Council of Doctors and the Board of Trustees of the University of Barcelona for her contribution to scientific communication

03/04/19 - DBGen,

Professor Gemma Marfany, co-founder and associate director of DBGen Ocular Genomics, has been honored with the Distinction of the Council of Doctors and the Board of Trustees of the University of Barcelona (UB) in its sixth edition. The award ceremony was held on April 2, 2019, in the Aula Magna of the Historic Building of the UB. With this distinction,...

read more

World DNA day

Two intertwined lines, a glimpse of an helix... no doubt, this is the symbol of DNA. The structure of DNA has completely revolutionized our view of the world, the double helix allowed us to understand how genetic information is transmitted to progeny and how we could decypher the instructions encoded in genes. On 25th of April every year we celebrate...

read more

First cell therapy clinical assay for dry Age-Related Macular Degeneration

Dry Age-Related Macular Degeneration (ARMD) is a frequent retinal neurodegenerative disorder that eventually leads to severe blindness. ARMD is a complex disease, triggered by several environmental as well as susceptibility genetic factors. There is no current effective treatment that can halt the progressive loss of retinal pigment epithelium, the phenotypic hallmark of ARMD. Very promising results have been recently reported...

read more

Spanish press recognizes our work and commitment

On Sunday, April 1st, the prestigious newspaper La Vanguardia in its printed version published an article about our company and our commitment to the people that suffers one of the more than 500 visual pathologies that have a genetic basis. The article highlights several characteristics of DBGen such as our commitment to innovation through the establishment of a cutting-edge science...

read more
Copyright © 2019. All Rights Reserved -